Une seule dose peropératoire de ketorolac original pour prévenir les récidives de cancer

Serait-ce trop simple?

Translated title of the contribution: A single intraoperative dose of original ketorolac to prevent cancer recurrence: Is that too simple?

P. Forget* (Corresponding Author), M. De Kock

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

Perioperative tumor growth acceleration is associated with inflammatory pathway activation. Non-steroidal anti-inflammatory drugs, particularly ketorolac, are a promising way to improve patient outcome.
Original languageUndefined/Unknown
Pages (from-to)391-395
Number of pages5
JournalLouvain Medical
Volume133
Issue number6
Publication statusPublished - Jun 2014

Fingerprint

Ketorolac
Anti-Inflammatory Agents
Recurrence
Growth
Pharmaceutical Preparations
Neoplasms

Keywords

  • Ketorolac
  • postoperative cancer recurrence
  • Inflammation

Cite this

Une seule dose peropératoire de ketorolac original pour prévenir les récidives de cancer : Serait-ce trop simple? / Forget, P. (Corresponding Author); De Kock, M.

In: Louvain Medical, Vol. 133, No. 6, 06.2014, p. 391-395.

Research output: Contribution to journalArticle

@article{5f68868ce4fd4aea865517ce13ffaf6c,
title = "Une seule dose perop{\'e}ratoire de ketorolac original pour pr{\'e}venir les r{\'e}cidives de cancer: Serait-ce trop simple?",
abstract = "Perioperative tumor growth acceleration is associated with inflammatory pathway activation. Non-steroidal anti-inflammatory drugs, particularly ketorolac, are a promising way to improve patient outcome.",
keywords = "Ketorolac, postoperative cancer recurrence, Inflammation",
author = "P. Forget and {De Kock}, M.",
year = "2014",
month = "6",
language = "Undefined/Unknown",
volume = "133",
pages = "391--395",
journal = "Louvain Medical",
number = "6",

}

TY - JOUR

T1 - Une seule dose peropératoire de ketorolac original pour prévenir les récidives de cancer

T2 - Serait-ce trop simple?

AU - Forget, P.

AU - De Kock, M.

PY - 2014/6

Y1 - 2014/6

N2 - Perioperative tumor growth acceleration is associated with inflammatory pathway activation. Non-steroidal anti-inflammatory drugs, particularly ketorolac, are a promising way to improve patient outcome.

AB - Perioperative tumor growth acceleration is associated with inflammatory pathway activation. Non-steroidal anti-inflammatory drugs, particularly ketorolac, are a promising way to improve patient outcome.

KW - Ketorolac

KW - postoperative cancer recurrence

KW - Inflammation

UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-84942097786&partnerID=MN8TOARS

M3 - Article

VL - 133

SP - 391

EP - 395

JO - Louvain Medical

JF - Louvain Medical

IS - 6

ER -